STOCK TITAN

Korsana Biosciences: Balyasny reports ~1.26% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Korsana Biosciences, Inc. (KRSA) Schedule 13G/A reports that Balyasny Asset Management L.P., its general partner BAM GP LLC, BAM GP’s sole member Balyasny Asset Management Holdings LP, that partnership’s general partner Dames GP LLC, and Dames’ managing member Dmitry Balyasny each may be deemed to beneficially own the same 572,533 shares, approximately 1.26% of the class.

The shares are directly held by Atlas Private Holdings (Cayman) Ltd. (570,064 shares) and Atlas Diversified Master Fund, Ltd. (2,469 shares), both investment-management clients of Balyasny Asset Management L.P. The issuer reported 45,541,425 shares outstanding as of September 8, 2026. Each reporting person reported sole voting and dispositive power over 572,533 shares and no shared power.

Beneficially owned shares 572,533 shares Each of the five reporting persons may be deemed to beneficially own the same shares.
Reported ownership percentage Approximately 1.26% Percentage of the common stock for each reporting person.
Shares outstanding 45,541,425 shares As of September 8, 2026, the basis cited for the ownership percentage.
Shares held by Atlas Private Holdings (Cayman) Ltd. 570,064 shares Directly held; the entity is an investment-management client of Balyasny Asset Management L.P.
Shares held by Atlas Diversified Master Fund, Ltd. 2,469 shares Directly held; the entity is an investment-management client of Balyasny Asset Management L.P.
beneficially own regulatory
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole power to vote regulatory
"Sole power to vote or to direct the vote"
sole power to dispose regulatory
"Sole power to dispose or to direct the disposition"
investment manager technical
"its position as the investment manager of Atlas Private Holdings"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of KRSA did the Balyasny reporting persons report owning?

Each reporting person may be deemed to beneficially own approximately 1.26% of Korsana Biosciences’ common stock, or 572,533 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





23255M303

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading